Irena Đjunić

458 total citations
32 papers, 306 citations indexed

About

Irena Đjunić is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Irena Đjunić has authored 32 papers receiving a total of 306 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Hematology, 8 papers in Genetics and 7 papers in Molecular Biology. Recurrent topics in Irena Đjunić's work include Acute Myeloid Leukemia Research (12 papers), Multiple Myeloma Research and Treatments (8 papers) and Platelet Disorders and Treatments (5 papers). Irena Đjunić is often cited by papers focused on Acute Myeloid Leukemia Research (12 papers), Multiple Myeloma Research and Treatments (8 papers) and Platelet Disorders and Treatments (5 papers). Irena Đjunić collaborates with scholars based in Serbia, Czechia and Switzerland. Irena Đjunić's co-authors include Ana Vidović, Nada Suvajdžić, Dragica Tomin, Marijana Virijević, Ivo Elezović, Nataša Čolović, Mirjana Mitrović, Darko Antić, Nataša Milić and Andrija Bogdanović and has published in prestigious journals such as International Journal of Molecular Sciences, Medicine and Frontiers in Pharmacology.

In The Last Decade

Irena Đjunić

30 papers receiving 299 citations

Peers

Irena Đjunić

HEMAT

GENET

ONCOL

PHEOH

Marijana Virijević Serbia

Ambra Di Veroli Italy

Francisco Aranha Brazil

Bensinger Wi United States

Mary Horowitz United States

J-H Bourhis France

G Geissler Germany

Luca Facchini Italy

Gerald Gilchrist United States

Marek J. Bozdech United States

Marijana Virijević Serbia

Irena Đjunić

204 ×0.9

HEMAT

112 ×1.3

62 ×0.8

GENET

47 ×0.8

ONCOL

54 ×1.6

PHEOH

Citations per year, relative to Irena Đjunić Irena Đjunić (= 1×) peers Marijana Virijević

Countries citing papers authored by Irena Đjunić

Since Specialization

Citations

This map shows the geographic impact of Irena Đjunić's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Irena Đjunić with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Irena Đjunić more than expected).

Fields of papers citing papers by Irena Đjunić

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Irena Đjunić. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Irena Đjunić. The network helps show where Irena Đjunić may publish in the future.

Co-authorship network of co-authors of Irena Đjunić

This figure shows the co-authorship network connecting the top 25 collaborators of Irena Đjunić. A scholar is included among the top collaborators of Irena Đjunić based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Irena Đjunić. Irena Đjunić is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ivanović, Jelena, Milena Mitrović, Nada Suvajdžić, et al.. (2025). Managing novel therapies and concomitant medications in chronic lymphocytic leukemia: key challenges. Frontiers in Pharmacology. 15. 1517972–1517972.

Virijević, Marijana, Zoran Bukumirić, Nada Suvajdžić, et al.. (2024). Risk Factors for Venous Thromboembolism in Acute Promyelocytic Leukemia. Cancers. 16(24). 4209–4209.

Miljanovic, Danijela, et al.. (2024). Significance of Cytomegalovirus gB Genotypes in Adult Patients Undergoing Hematopoietic Stem Cell Transplantation: Insights from a Single-Centre Investigation. Pharmaceuticals. 17(4). 428–428. 3 indexed citations

Milićević, Ognjen, et al.. (2024). Human Cytomegalovirus Oncoprotection across Diverse Populations, Tumor Histologies, and Age Groups: The Relevance for Prospective Vaccinal Therapy. International Journal of Molecular Sciences. 25(7). 3741–3741. 2 indexed citations

Virijević, Marijana, Mirjana Mitrović, Irena Đjunić, et al.. (2024). Incidence, risk factors, and outcome of asymptomatic central nervous system involvement in adult patients with acute myeloid leukemia. Hematological Oncology. 42(2). e3253–e3253. 4 indexed citations

Todorović, Milena, Jelena Bila, Bela Balint, et al.. (2018). Influence of applied CD34+ cell dose on the survival of Hodgkin's lymphoma and multiple myeloma patients following autologous stem cell transplants. Vojnosanitetski pregled. 77(8). 844–851. 5 indexed citations

Đjunić, Irena, et al.. (2015). Favorable Outcome of Budd-Chiari Syndrome in Acute Promyelocytic Leukemia. 2(5). 126–130. 1 indexed citations

Čolović, Nataša, et al.. (2015). Favorable outcome of hepatosplenic candidiasis in a patient with acute leukemia. Srpski arhiv za celokupno lekarstvo. 143(5-6). 341–345. 1 indexed citations

Virijević, Marijana, et al.. (2014). Pretreatment risk factors for overall survival in patients with gastrointestinal and non-gastrointestinal mucosa associated lymphoid tissue lymphomas.. PubMed. 19(1). 178–82. 2 indexed citations

10.

Đjunić, Irena, Ivo Elezović, Vesna Ilić, et al.. (2013). Specific Binding of Paraprotein to Platelet Receptors as a Cause of Platelet Dysfunction in Monoclonal Gammopathies. Acta Haematologica. 130(2). 101–107. 12 indexed citations

11.

Vidović, Ana, et al.. (2013). Proven invasive pulmonary mucormycosis successfully treated with amphotericin B and surgery in patient with acute myeloblastic leukemia: a case report. Journal of Medical Case Reports. 7(1). 263–263. 14 indexed citations

12.

Suvajdžić, Nada, Irena Đjunić, Ana Vidović, et al.. (2013). Health-related quality of life in adult patients with chronic immune thrombocytopenia in Serbia. Platelets. 25(6). 467–469. 11 indexed citations

13.

Đjunić, Irena, Nada Suvajdžić, Marijana Virijević, et al.. (2012). Prognostic risk score for the survival of elderly patients with acute myeloid leukaemia comprising comorbidities. Medical Oncology. 30(1). 394–394. 9 indexed citations

14.

Antić, Darko, Ivo Elezović, Nataša Milić, et al.. (2012). Is there a “gold” standard treatment for patients with isolated myeloid sarcoma?. Biomedicine & Pharmacotherapy. 67(1). 72–77. 70 indexed citations

15.

Suvajdžić, Nada, Zorica Cvetković, Vesna Đorđević, et al.. (2012). Prognostic factors for therapy-related acute myeloid leukaemia (t-AML) – A single centre experience. Biomedicine & Pharmacotherapy. 66(4). 285–292. 4 indexed citations

16.

Đjunić, Irena, Marijana Virijević, Nataša Čolović, et al.. (2011). Prognostic significance of CD56 antigen expression in patients with acute myeloid leukemia. Medical Oncology. 29(3). 2077–2082. 12 indexed citations

17.

Čolović, Nataša, Dragica Tomin, Ana Vidović, et al.. (2011). Pretreatment prognostic factors for overall survival in primary resistant acute myeloid leukemia. Biomedicine & Pharmacotherapy. 66(8). 578–582. 8 indexed citations

18.

Đjunić, Irena, et al.. (2011). Simultaneous Presentation of Hairy Cell Leukemia and Metastatic Signet Ring Carcinoma of the Stomach Diagnosed by Bone Marrow Biopsy. Applied immunohistochemistry & molecular morphology. 19(3). 279–282. 3 indexed citations

19.

Đjunić, Irena, Ivo Elezović, Milica Marinkovic, et al.. (2010). Osteolytic lesions marker in multiple myeloma. Medical Oncology. 28(1). 237–240. 9 indexed citations

20.

Vidović, Ana, et al.. (2009). Prognostic significance of cellular vascular endothelial growth factor (VEGF) expression in the course of chronic myeloid leukaemia. Srpski arhiv za celokupno lekarstvo. 137(7-8). 379–383. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact